News

'Superbabies' Startup Seeks Funds for Controversial Gene Editing Push

By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.

Bootstrap Bio...

Patents & Other IP

Can doctors test embryos for autism? And should they?

By Brittany Luse, Liam McBain, and Neena Pathak, NPR [cites CGS' Katie Hasson] | 05.28.2025

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These conditions are informed by many genetic variants and environmental factors - so...

Genetic Selection

Why Deleting Your 23andMe Data Is a Political Imperative

By Katie Sagaser, The DNA Exchange | 05.27.2025

Disclaimer: The views and opinions expressed in this piece are solely my own and do not represent those of my...

U.S. Federal

Trumpian “Common Sense” and the History of IQ Tests

By Pepper Stetler, Los Angeles Review of Books | 05.08.2025

^{"Donald Trump Signs The Pledge" by Michael Vadon

is licensed under CC BY-SA 2.0.}

This is...

Society

Disabled People Can Still Be Forcibly Sterilized in Over Half of the US

By Rewire News Group Staff, Rewire News Group | 01.25.2022

A National Women’s Law Center report released today shines a light on the dark reality of modern-day eugenics.

More than...

U.S. States

On the road to treating mitochondrial disease

By Danielle Gerhard, Drug Discovery News | 01.24.2022

^{"Abnormal Mouse Mitochondria"

by National Institutes of Health (NIH)

is licensed under CC BY 2.0}

Mitochondrial disease, whether...

Human Genetic Modification

A crowd of women holding up white flags and a white banner that reads "MARCH FOR LIFE" in red

White nationalists are flocking to the US anti-abortion movement

By Moira Donegan, The Guardian | 01.24.2022

^{Photo by Steve Sanchez on Shutterstock}

This weekend’s March for Life rally, the large anti-choice demonstration held annually in Washington...

Eugenics

Some egg donor agencies advertise $275,000 paychecks on social media — but the rigorous process is a far cry from making a 'quick buck'

By Hannah Towey, Business Insider | 01.23.2022

The complex nature of the egg donation business is baked right into the name. A careful balancing act between...

U.S. Federal

A $3bn bet on finding the fountain of youth

By Staff, The Economist | 01.22.2022

Startups come and startups go. But few startups start with $3bn in the bank. Yet that is the fortunate position in...

Stem Cells

Their DNA Hides a Warning, but They Don’t Want to Know What It Says

By Gina Kolata, The New York Times | 01.21.2022

^{"Biobank" by UiT Norges arktiske universitet

is licensed under CC BY-NC-ND 2.0 via flickr}

Marin Konstadt, visiting family in...

U.S. Federal

Gloved hand holding a test tube labeled "DNA TEST"

Voluntary workplace genomic testing: wellness benefit or Pandora’s box?

By Kunal Sanghavi, Betty Cohn, Anya E. R. Prince, W. Gregory Feero, Kerry A. Ryan, Kayte Spector-Bagdady, Wendy R. Uhlmann, Charles Lee, J. Scott Roberts & Debra J. H. Mathews, npj Genomic Medicine | 01.20.2022

Consumer interest in genetic and genomic testing is growing rapidly, with more than 26 million Americans having purchased direct-to-consumer (DTC)...

U.S. Federal

What’s Wrong with the FDA?

By Shannon Brownlee and Jeanne Lenzer, Washington Monthly | 01.20.2022

If Robert Califf, the White House nominee for commissioner of the U.S. Food and Drug Administration, is confirmed by the Senate...

U.S. Federal